Zanubrutinib Alternatives Compared
| Zanubrutinib | Imbruvica (ibrutinib) | Ibrutinib |
|
|---|
| Zanubrutinib | Imbruvica (ibrutinib) | Ibrutinib |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma. Zanubrutinib may also be used for purposes not listed in... View more |
Prescription only
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Prescription only
Ibrutinib is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Related suggestions Chronic Lymphocytic Leukemia
Waldenström Macroglobulinemia
|
|||||||
| More about Zanubrutinib | More about Imbruvica (ibrutinib) | More about Ibrutinib | ||||||||
| Ratings & Reviews | ||||||||||
|
Zanubrutinib has an average rating of 9.0 out of 10 from a total of 42 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Imbruvica has an average rating of 6.4 out of 10 from a total of 63 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 32% reported a negative effect. |
Ibrutinib has an average rating of 6.6 out of 10 from a total of 78 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Imbruvica prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Brukinsa |
N/A |
Imbruvica | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
4 hours |
6 hours |
6 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 476 drugs are known to interact with Zanubrutinib:
|
A total of 486 drugs are known to interact with Imbruvica:
|
A total of 486 drugs are known to interact with Ibrutinib:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
November 14, 2019 |
November 13, 2013 |
November 13, 2013 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.